Rochester, MN - A case report of a patient who suffered erosion of an Amplatzer septal-occluder device (St Jude Medical) six years after it was implanted, resulting in cardiac tamponade and ...

Golden Valley, MN The FDA Circulatory Systems Device Panel has recommended approval of the Amplatzer ® Septal Occluder along with the Amplatzer ® Delivery System for patients with secundum atrial ...

A novel study by Canadian physicians reported that the BioSTAR biodegradable implant achieved comparable closure rates to the Amplatzer Septal Occluder in children with atrial septal defect. A novel ...

Sahajanand Medical Technologies (SMT) is using its Cocoon Occluder devices to treat congenital heart defects like atrial septal defect and patent foramen ovale. These minimally invasive devices ...

St. Jude Medical (STJ) received an FDA safety alert for its Amplatzer ASO, a minimally-invasive implantable cardiac device used to treat atrial septal defect. The problem? In one to three of every ...

St. Jude Medical ($STJ) got sideswiped with an FDA safety alert over one of the company's heart plugs based on reports that it could potentially wear away tissue and ...

An ASD can be closed by a minimally invasive procedure. A catheter is inserted via a blood vessel in the groin and guided to the heart. The Occlutech ASD Occluder is a self-expanding Nitinol double ...

Leg-spinner Yuzvendra Chahal's maiden six-wicket for India as the hosts beat England by 75 runs in the third and final Twenty20 International ...

While rare, infective endocarditis is a devastating complication after device closure of atrial septal defects (ASDs), and much remains unknown about when infections begin and how clinicians can best ...

The AI model was more efficient at detecting signatures of atrial septal defect (ASD) in electrocardiograms (ECG) than traditional methods. A study from Ann & Robert H. Lurie Children's Hospital of ...

SCHAFFHAUSEN, CH / ACCESSWIRE / January 8, 2024 / Occlutech Holding AG Occlutech ASD Occluder delivers positive procedural outcomes with strong efficacy and a low rate of complications[i] Occlutech®, ...